Results 111 to 120 of about 2,804,350 (243)
Morphology of corneal nerves using Confocal Microscopy ( Confoscan 3) in the open angle glaucoma”
Morphology of corneal nerves using Confocal Microscopy ( Confoscan 3) in the open angle ...
DONATI S. +4 more
core
Three years of ocular proton therapy in the Netherlands, clinical results
Abstract Purpose Uveal melanoma (UM) is a rare cancer with rising number of diagnosis (143 diagnoses in 1990 to 226 in 2023) in the Netherlands. Most patients are treated locally with Ruthenium‐106 brachytherapy (±102/year). Patients were referred for proton therapy (PT) to Switzerland in the past, but PT is available in the Netherlands from January ...
C. Rasch +14 more
wiley +1 more source
Abstract Purpose To evaluate changes in the prevalence and incidence of type 2 diabetes, the association between type 2 diabetes and diabetic retinopathy (DR), and the impact of type 2 diabetes and DR on visual acuity (VA) in Finland during 2000–2017. Methods We used three nationwide health examination surveys conducted in 2000, 2011 and 2017, with a ...
Petri Purola +4 more
wiley +1 more source
Pharmacological Treatment of Glaucoma
Glaucoma is e degenerative neuropathic disease which can be divided in to open angle glaucoma and close angle glaucoma. The main focus of this thesis is pharmacological treatment of open angle glaucoma.
Paydar, Bassam
core
Clinical outcomes of the PAUL® glaucoma implant for secondary glaucoma
Abstract Purpose Secondary glaucoma encompasses a broad spectrum of disease entities arising from diverse ocular pathologies and is often refractory to conventional treatment. Glaucoma drainage devices (GDDs) have therefore become an important surgical option.
Carolin Deubel +7 more
wiley +1 more source
Abstract Purpose To evaluate the outcomes of intraluminal stent removal from the Paul glaucoma implant (PGI). Methods A retrospective observational study of all cases undergoing PGI stent removal from August 2022 to August 2025 at a single Danish tertiary centre. Primary endpoints were intraocular pressure (IOP) and IOP‐lowering medications.
Anne Studsgaard +2 more
wiley +1 more source
Baerveldt implant for secondary glaucoma due to iris melanoma
Annelie N Tan1, Juliette GMM Hoevenaars1, Carroll AB Webers1, Bertil Damato2, Henny JM Beckers11University Eye Clinic, Maastricht, The Netherlands; 2Ocular Oncology Service Royal Liverpool University Hospital, Liverpool, United KingdomBackground: Proton ...
Juliette GMM Hoevenaars +3 more
core
Abstract Purpose Fovea‐sparing geographic atrophy (GA) patients retain near‐normal central vision. To better understand GA progression in relation to the fovea, we performed a semi‐automated image analysis of regional atrophy growth in a long‐term GA natural‐history cohort. Methods Prospective‐observational, single‐centre‐study (02/2013–07/2025) at the
Daniel R. Muth +8 more
wiley +1 more source
Neovascular glaucoma at a tertiary Centre in Finland, 2008–2024: A retrospective cohort study
Abstract Purpose Neovascular glaucoma (NVG) is a refractory secondary glaucoma, yet longitudinal outcome data remain limited. This study reports its aetiologies, treatments and outcomes. Methods Patients with NVG were identified through electronic medical record review.
Gilbert Simons +3 more
wiley +1 more source
Glaucoma associated with the management of rhegmatogenous retinal detachment
George Mangouritsas, Spyridon Mourtzoukos, Dimitra M Portaliou, Vassilios I Georgopoulos, Anastasia Dimopoulou, Elias Feretis Eye Clinic, General Hospital "Hellenic Red Cross", Athens, Greece Abstract: Transient or permanent elevation of intraocular ...
Mangouritsas G +5 more
doaj

